Biblio
.
. .
.
Directed Differentiation of Human-Induced Pluripotent Stem Cells to Mesenchymal Stem Cells. Methods Mol Biol. 2016;1416:289-298.
. Empagliflozin Ammeliorates High Glucose Induced-Cardiac Dysfuntion in Human iPSC-Derived Cardiomyocytes. Sci Rep. 2018;8(1):14872.
. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation. Stem Cell Res. 2019;37:101437.
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation. Stem Cell Res. 2019;37:101431.
Directed Differentiation of Notochord-like and Nucleus Pulposus-like Cells Using Human Pluripotent Stem Cells. Cell Rep. 2020;30(8):2791-2806.e5.
Generation of a human iPSC line GIBHi002-A-2 with a dual-reporter for NKX2-5 using TALENs. Stem Cell Res. 2020;50:102120.
Generation of GADD45A gene knockout human embryonic stem cell line using CRISPR/Cas9. Stem Cell Res. 2020;49:102090.
. Management of adrenoleukodystrophy: From pre-clinical studies to the development of new therapies. Biomed Pharmacother. 2021;143:112214.
. Mesenchymal stromal cell-derived exosomes in cardiac regeneration and repair. Stem Cell Reports. 2021.
. Generation of a human iPSC line CIBi010-A with a reporter for ASGR1 using CRISPR/Cas9. Stem Cell Res. 2022;62:102800.
Liposome-encapsulated curcumin attenuates HMGB1-mediated hepatic inflammation and fibrosis in a murine model of Wilson's disease. Biomed Pharmacother. 2022;152:113197.
Bradykinin-pretreated Human cardiac-specific c-kit Cells Enhance Exosomal miR-3059-5p and Promote Angiogenesis Against Hindlimb Ischemia in mice. Stem Cell Rev Rep. 2023.
Dietary modification for prevention and control of high blood pressure. Postgrad Med J. 2023.
. Expanding Indications for Pulse Field Ablation Beyond Treatment of Cardiac Arrhythmias?. Heart Rhythm. 2023.
. Primary Prevention of Sudden Cardiac Death in Asia. JACC Asia. 2023;3(3):346-348.
. Targeting Cardiac Conduction System as Pacing for Heart Failure. JACC Clin Electrophysiol. 2023.
. . Aromatase Inhibitor Therapy Increases the Risk of New-Onset Atrial Fibrillation in Patients With Breast Cancer. JACC Asia. 2024;4(2):150-160.